Spanish pharmaceutical company Zendal and IAVI partner to advance the tuberculosis vaccine candidate MTBVAC into efficacy trials

PORRIÑO, Spain & NEW YORK--(BUSINESS WIRE)-- #StopTB--Biofabri and IAVI will partner on promising tuberculosis vaccine candidate MTBVAC as alternative to BCG and to prevent TB disease in adults.